We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-12.59%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$6.47B
AUM Growth
-$1.17B
Cap. Flow
+$229M
Cap. Flow %
3.54%
Top 10 Hldgs %
71.2%
Holding
88
New
3
Increased
8
Reduced
7
Closed
12

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$271M
2
CRM icon
Salesforce
CRM
+$190M
3
LI icon
Li Auto
LI
+$121M
4
YSG
Yatsen Holding
YSG
+$113M
5
ENFN
Enfusion, Inc.
ENFN
+$101M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$205M
2
BEAM icon
Beam Therapeutics
BEAM
+$126M
3
BABA icon
Alibaba
BABA
+$106M
4
ILMN icon
Illumina
ILMN
+$68M
5
BILI icon
Bilibili
BILI
+$42.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.41%
2 Consumer Discretionary 29.78%
3 Technology 11.51%
4 Communication Services 4.08%
5 Consumer Staples 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
26
Tango Therapeutics
TNGX
$4.22B
$42.4M 0.65%
3,873,982
-500,000
-11% -$6.01M
ARGX icon
27
argenx
ARGX
$55B
$42M 0.65%
120,000
– –
TIL icon
28
Instil Bio
TIL
$49M
$40.8M 0.63%
119,273
– –
KNSA icon
29
Kiniksa Pharmaceuticals
KNSA
$6.18B
$34.4M 0.53%
2,920,023
– –
XPEV icon
30
XPeng
XPEV
$12.6B
$33.5M 0.52%
666,500
+546,500
+455% +$24.6M
AKRO
31
DELISTED
Akero Therapeutics
AKRO
$28.7M 0.44%
1,359,152
-181,313
-12% -$4.02M
ALGS icon
32
Aligos Therapeutics
ALGS
$26.1M
$28.1M 0.43%
94,603
– –
SHCO
33
DELISTED
Soho House & Co
SHCO
$25.7M 0.4%
2,009,509
-1,698,532
-46% -$20.3M
ABNB icon
34
Airbnb
ABNB
$91.3B
$24.8M 0.38%
148,760
– –
HTHT icon
35
Huazhu Hotels Group
HTHT
$13.3B
$21.6M 0.33%
578,902
– –
SNOW icon
36
Snowflake
SNOW
$99.2B
$21.3M 0.33%
63,000
– –
ACMR icon
37
ACM Research
ACMR
$4.58B
$19.1M 0.29%
670,755
– –
BZ icon
38
Kanzhun
BZ
$7.22B
$18.3M 0.28%
525,000
-525,000
-50% -$18.4M
MLCO icon
39
Melco Resorts & Entertainment
MLCO
$2.21B
$17.3M 0.27%
1,698,877
– –
FMTX
40
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$15.6M 0.24%
1,100,000
– –
RGNX icon
41
Regenxbio
RGNX
$617M
$14.9M 0.23%
456,000
– –
SOHU
42
Sohu.com
SOHU
$354M
$13.1M 0.2%
802,034
– –
PDD icon
43
Pinduoduo
PDD
$126B
$12.4M 0.19%
213,000
-2,595,000
-92% -$205M
ALLO icon
44
Allogene Therapeutics
ALLO
$614M
$11.9M 0.18%
800,000
– –
DYN icon
45
Dyne Therapeutics
DYN
$4.13B
$11.9M 0.18%
1,000,000
– –
TRML
46
DELISTED
Tourmaline Bio
TRML
$11.6M 0.18%
76,189
– –
NIO icon
47
NIO
NIO
$12B
$11.1M 0.17%
350,000
-509,200
-59% -$18.7M
TUYA
48
Tuya Inc
TUYA
$1.04B
$10.6M 0.16%
1,689,359
– –
ADCT icon
49
ADC Therapeutics
ADCT
$140M
$10.1M 0.16%
500,000
– –
IPSC icon
50
Century Therapeutics
IPSC
$364M
$9.74M 0.15%
614,095
– –
1
2
3 4

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, HHLR Advisors held 88 positions worth $6.47B, down 15% from $7.65B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

HHLR Advisors deployed $229M of net new capital in Q4 2021, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was Enfusion, Inc.: 4,975,183 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Pinduoduo, an estimated $205M trimmed.

  • HHLR Advisors's largest Q4 2021 buy was Enfusion, Inc.: 4,975,183 shares worth $104M.
  • HHLR Advisors added most to Sea Limited in Q4 2021, an estimated $271M increase.
  • HHLR Advisors's biggest Q4 2021 reduction was Pinduoduo, cutting an estimated $205M.
  • HHLR Advisors fully exited Beam Therapeutics in Q4 2021, selling an estimated $126M.
  • HHLR Advisors's ten largest holdings make up 71% of its $6.47B portfolio in Q4 2021.
  • HHLR Advisors opened 3 new positions and closed 12 in Q4 2021.
  • HHLR Advisors's portfolio value fell 15% quarter-over-quarter to $6.47B.

Based on HHLR Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.